Treating Kidney Cancer
with Cryoablation 

Choose a Minimally Invasive Treatment

At IceCure, we believe patients with kidney cancer* deserve a minimally invasive treatment choice. IceCure’s FDA and CE-marked ProSense Cryoablation System offers a fast, safe and effective minimally-invasive procedure for the treatment of benign and cancerous kidney tumors with minimal pain and scarring.

Large studies show cryoablation for kidney cancer has comparable oncological outcomes to surgery, with fewer complications and a shorter hospital stay1.

It’s Your Choice.

1 Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology, 30(5), 706-720. doi: 10.1093/annonc/mdz056.

*IceCure has regulatory approvals worldwide and clinical indications may vary by region. Please contact us for additional information.

Kidney Tumors

Treating Breast Tumors with Cryoablation

Choose cryoablation with IceCure first

At IceCure, we believe in choice. The ProSense Cryoablation System expands choice by providing a minimally invasive option to freeze and destroy breast tumors without removing them (lumpectomy), allowing women to maintain the shape of their breast. ProSense uniquely enables a fast and convenient office-based procedure with minimal pain and fewer complications compared to surgical alternatives.

It’s Your Choice.

1 Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology, 30(5), 706-720. doi: 10.1093/annonc/mdz056.

*IceCure has regulatory approvals worldwide and clinical indications may vary by region. Please contact us for additional information.

Choose Results

Interim findings from the landmark ICESECRET study currently underway found ProSense Cryoablation System to be a safe and effective treatment method for kidney lesions smaller than 5 cm. 

89.5%

Of patients were recurrence free at 22 months2

100%

Of physicians reported no significant device-related adverse events or complications2

25

Minute cryoablation procedure time on average2

2IceCure Medical Ltd. (2022, December 19). IceCure’s ProSense Safe and Effective in Treating Kidney Tumors With 89.5% Recurrence-Free Rate Based on Interim Study Results. Cryoablation procedure time refers to the time of the freeze-thaw-freeze cycles.

Testimonials

“Cryoablation for renal tumors is feasible, safe, efficient, cost-effective with a low complication rate and can easily be repeated. It is a noticeably quick procedure compared to surgery; patients we treat in the morning are heading to lunch by noon.”

PROF. OFER NATIV
HEAD OF THE UROLOGICAL DEPARTMENT AT THE BNAI ZION MEDICAL CENTER AND ELISHA HOSPITAL

Choose a Better Treatment Experience

With minimal pain, scarring and a faster recovery, ProSense’s minimally invasive cryoablation procedure offers an enhanced treatment experience:

  • Fast and easy procedure: Cryoablation procedure takes about 1 hour from start to finish helping save physicians time and reduce waiting times
  • Rapid recovery: Overnight hospital stay on average for observation, helping lower hospital costs with some patients able to go home that same day
  • Minimal pain and discomfort: Only a small incision is made for the needle-like cryoprobe and the cooling from the cryoablation itself reduces pain
  • Can be performed under light sedation: Eliminates risks from general anesthesia required during surgery
  • Works with existing chemotherapy, radiation, or immunotherapy
  • Repeatable procedure: Allows for further treatment and potentially reduces the impact of higher local recurrence after a single ablation3
  • Suitable for patients who have had a partial nephrectomy: Cryoablation targets only a small area of the organ leaving healthy tissue intact
  • Easy to use and efficient: Powerful liquid nitrogen freezing without gas line restrictions, user friendly touch screen system and unique single cryoprobe system helps saves time and cost
3Mershon JP. et al. Thermal ablation of the small renal mass: a critical analysis of current literature. Minerva Urol Nefrol. 2020 Apr;72(2):123-134. doi: 10.23736/S0393-2249.19.03572-0.

Choose Cryoablation for Advanced Kidney Care 

Cryoablation for kidney tumors is a fast, safe and effective minimally invasive procedure providing an additional treatment option to higher-risk surgical interventions. Using CT imaging, a small cryoprobe (like a thin hollow needle) is guided into the tumor and the ice ball growth is monitored. Extremely cold temperatures are applied to freeze and destroy the benign or cancerous tissue. 

Resources

Webinars

Webinar: Cryoablation in the Thoracic Cavity

This webinar lead by Dr. Julien Frandon of the Department of Radiology at CHU de Nîmes discusses various cases performed with the ProSense™ Liquid Nitrogen (LN2) Based Cryoablation System in the thoracic cavity (i.e. lung, mediastinum). (60 minutes)

Read More >

Publications

Feasibility and Safety of Single-Probe Cryoablation with Liquid Nitrogen: An Initial Experience in 24 Various Tumor Lesions

The aim of this retrospective study was to assess the feasibility of the IceCure’s single-probe liquid nitrogen system for tumor lesions of various sizes and locations, and to evaluate the safety of cryoablation with this technique.

Read More >

Publications

Cryoablation Using Liquid Nitrogen for Metastatic Lung Cancers

This retrospective observational study conducted by Professor Hiroaki Nomori, MD found that cryoablation using liquid nitrogen would be one of the treatment methods for metastatic lung cancers <2.2 cm; and pulmonary function decreased significantly when cryoablation was performed for an

Read More >